Moore Alison
Visual SEC Form 4 history across 2 companies, 4 transactions and 3 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
No open-market insider purchase is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ARTV | MOORE ALISON | DIR | grant | 13.7k | $0 | A | 0.0% | 09/08 | 09/08 | |
| CDXS | MOORE ALISON | PRES | sale | 3.82k | -$500k | S | +120.9% | 02/09 | 02/06 | |
| CDXS | MOORE ALISON | CTO | grant | 161k | $0 | A | — | 02/08/2025 | 02/05/2025 | |
| CDXS | MOORE ALISON | CTO | grant | 26.8k | $0 | A | — | 02/08/2025 | 02/05/2025 |
Moore Alison Insider Activity FAQ
SEC Form 4 context
Who is Moore Alison?
Moore Alison is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001754937.
Which companies has Moore Alison reported transactions for?
Artiva Biotherapeutics, Inc., CODEXIS, INC.
When was Moore Alison's latest insider buy?
No open-market insider purchase is available for this period.
When was Moore Alison's latest insider sale?
sale at CODEXIS, INC. on Feb 06, 2026 valued at $5,001.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.